International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 3108-3120
Research Article
The Long-Term Impact of Covid -19 on Cardiac Autonomic Function in Young Adults Assessed by Heart Rate Variability
 ,
 ,
Received
June 21, 2026
Accepted
July 10, 2026
Published
July 25, 2026
Abstract

INTRODUCTION: COVID - 19 had created long term impact on recovered patients in various systems of the body and it is termed as Long Covid. Involvement of autonomic nervous system in long covid patients can lead to dysfunction of vital organs including the cardio vascular system. Heart Rate Variability (HRV) is a non invasive measure of autonomic function that facilitates identification of Long covid patients at risk of developing cardiovascular complications.

AIM: To assess the long term impact of COVID -19 on cardiac autonomic function in young adults using Heart Rate Variability.

Methods: It is an observational and comparative study comprising of two groups. Group 1 (unaffected by COVID -19) and Group 2 (recovered from COVID -19, minimum of three months gap after infection at the time of recruitment and Real time Polymerase Chain Reaction (RT - PCR) for Covid -19 tested positive). Age and Gender matched for both the groups. Anthropological measurements were taken. The short term HRV was recorded in Research lab, Department of Physiology, DSMCH. Cardio vascular parameters like Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP) were measured and compared between two groups.

HRV parameters:1. Time Domain Parameters like Mean Heart Rate (Mean HR), (SDNN), (RMSSD) and (PNN50) were measured and compared between two groups.

  1. Frequency Domain Parameters like Low Frequency (LF nu), High Frequency (HF nu) and LF/ HF ratio were measured and compared between two groups.

Data was analyzed using JASP Software version: 0.19.3. Statistical analysis tests used were Mann Whitney U test and Odds ratio analysis.

Results: HRV showing statistically significant lower Time domain parameters like SDNN (P value : < 0.018) and RMSSD (P value : < 0.046) in the Group - 2 individuals which indicates that the parasympathetic activities were decreased in them.

Conclusion: Our study results showed decreased parasympathetic activity in Group - 2 than Group -1 individuals. There is a long term impact of Covid - 19 on cardiac autonomic function causing cardiac dysautonomia. Early diagnosis of cardiac dysautonomia due to COVID -19 in young adults can prevent incidence of cardiac morbidities and mortalities in future.

Keywords
INTRODUCTION

It has been observed that many people diagnosed with Long covid syndrome had autonomic dysfunction 1. The regulation and integration of internal organs is done by the autonomic nervous system. It helps in the adaptation of internal environment to changes in the external environment2 . The relationship between COVID 19 and autonomic nervous system is due to cytokine storm response. The cytokine storm during COVID 19 infection leads to activation of sympathetic system inducing release of proinflammatory cytokines, conversely the stimulation of vagus nerve results in anti-inflammatory response 3. The over activation of the sympathetic or parasympathetic components of the autonomic nervous system is referred as“Dysautonomia”. The patho-physiology of autonomic dysfunction in Long covid syndrome is due to the SARS - COV-2 virus having a high affinity for medulla oblongata, involving Nucleus Tractus Solitarius and ventrolateral medulla. Since these areas have high ACE -2 receptors. Though respiratory tract is the major target for SARS - COV -2 Virus. Cardiovascular involvement has also been reported in post covid patients. It is very important to diagnose cardiac dysautonomia in general population, because in cardiac dyasautonomia / cardiac autonomic neuropathy, there is a defect in the sympathetic and parasympathetic supply of the heart which leads to arrhythmias, coronary vessel ischemia and sudden death syndrome. Mostly, Cardiac dysautonomia remains subclinical and present as altered Heart Rate Variability. In early phase, it may present as resting tachycardia and in advanced stage, it may cause exercise intolerance, cardiomyopathy with left ventricular dystrophy, orthostatic

 

NEED FOR MEASURING CARDIAC AUTONOMIC FUNCTION USING HEART RATE  VARIABILITY  IN  POST  COVID YOUNG ADULTS:

Several clinical manifestations have been documented in Long covid syndrome patients. But their impact on cardiovascular and autonomic nervous system in a younger population remain unclear. Thus, this study was conducted to examine whether there is any alterations in cardiac autonomic function in young individuals who were affected with Covid -19 in the past 4. Appropriate clinical checkup could be needed in future for Long covid cases who had cardiac dysautonomia which in turn helps us to prevent the incidence of myocardial infarction, coronary artery disease, sudden death and also aids in early diagnosis and treatment 5.

 

MATERIALS AND METHODS

STUDY DESIGN: It is an observational & cross sectional study. The study was conducted in the Research laboratory of Department of Physiology, Dhanalakshmi Srinivasan Medical college and Hospital, Siruvachur, Perambalur.. This study was conducted from August 2023 to July 2024.

 

The sample size calculation led to the formation of two groups Group I cases without COVID 19 (50 cases

Group II cases with COVID 19 (50 cases)

 

METHODOLOGY:  

Total of 100 young adults of both male and female aged between 18 and 30 years were selected . Out of 100 subjects , 50 were categorized as Group 1(Never been diagnosed covid with RT - PCR) and other 50 were Categorized as Group 2 (RT PCR Positive for Covid -19). Gender was matched between two groups . In Group 1 , 25 males and 25 females were recruited and in Group 2 also, 25 males and 25 females were recruited. Both the groups were clearly explained about the study procedure, a written informed consent was obtained from study subjects. They were asked to fill the data proforma consisting of demographic details and clinical history. After clinically examining the participants, height was measured in (cm) ,weight in (kg) and BMI was measured using quetelets index (BMI = weight (Kg) / height ( m2)) . Waist circumference was measured as (cm) at the level of umblicus.

 

Cardiovascular parameters like Blood pressure and Pulse rate was measured and noted. HRV recording was done in a calm room at an optimum temperature(23 - 28 degree) without any bright light and noise .Subjects were asked to sit and relax for 5 minutes . ECG limb leads were placed and connected to the HRV recorder. Audacity software was opened , recording was done for continous duration of 2 minutes. Checked for any artifacts in the RR Tachogram. Then the RR Tachogram is transmitted to the Kubios software which analyses    the beat to beat variability of          the participants. Finally, Time domain and Frequency domain parameters of HRV were estimated. In Time domain analysis, rMSSD, pNN50, sDNN and Mean HR were measured. In Frequency domain analysis, LF, HF, LF/HF ratio were measured.

 

STATISTICAL ANALYSIS

Non Parametric test Mann Whitney U Test was used to compare the difference between two               independent variable. Here, P- Value < 0.05 taken as significant * and P- Value <0.01taken as highly significant .Study parameters for both the groups were  represented using Box and whisker plot. Risk ratio and      Odds ratio for low              SDNN and low RMSSD were estimated.

 

In the present study, based on selection criteria, (mentioned in the materials and methods) , the subjects were recruited and their history was recorded in the data proforma. A total of 100 Participants were recruited in the study. Out of 100 subjects, 50 subjects had no history of RT PCR Positive Covid -19 infection in the past and named as GROUP 1. Another 50 subjects had history of Covid -19 infection in the past and they were tested RT PCR positive for Covid -19 infection and named as GROUP 2 .

 

Figure 1 showing              recruitment process of participants in the study .

 

The age group of the participants ( n= 100 ) was from 18 to 30 years. Out of 100 participants, 50 were males and 50 were females. In group 1, there were 25 Covid negative males and 25 covid negative females .As seen in Figure no.6 and 7, In group 2 , there were 25 Covid Positive males and 25 covid positive females.

 

A detailed history regarding their year of covid infection was noted ( 2020,2021 ,2022) Among group -2 participants , 28  %  got diagnosed  with  COVID - 19 in the year of

2020, 56 % got diagnosed in the year of 2021 and 26 % got diagnosed in the year of 2022 (Figure no .9). For both the groups , their vaccination history for Covid -19 vaccine was noted . In Group 1, 94 % of participants had vaccination against Covid -19 and In Group 2 , 96 % of Participants had vaccination against Covid – 19. .No subjects had been taking any drugs like Beta blockers , Theophylline and Sedatives during the study period. No Participants reported any history of sudden cardiac death in their family .

 

FIGURE NO. 2: showing gender distribution in group 1 individuals.

 

FIGURE NO . 3: showing gender distribution in group 2 individuals.

 

FIGURE NO.4: showing  year of Covid infection in group -2 individuals.

 

FIGURE NO. 5: showing percentage of vaccination against Covid - 19          in group - 1 individuals.

 

FIGURE NO.6: showing percentage of vaccination against Covid - 19           in group - 2 individuals .

 

TABLE NO .1: Analysis  of           various anthropometric measurements     in the     study population ( n = 100 )

 

AGE

 

(years)

HEIGHT

 

(cms)

WEIGHT

 

(kgs)

BMI

 

(kg /m2)

MEAN

19

163.3

58.335

21.8

MEDIAN

19

164

57

21.24

IQR (75 th            -                                   25 th percentile )

1(19 -18)

13 (168– 155 )

18.25(67 - 48 .75 )

5.75 (24.82

-19.06 )

STANDARD

 

DEVIATION

1.93

9.36

12.48

4.01

MINIMUM

18

141

30

15.09

MAXIMUM

30

188

95

32.44

 

OBSERVATION: Mean age of        all participants was 19. Mean height was 163 .3 cm and mean weight was 58.335 kg . Mean BMI recorded was 21.8 kg /m2 .

 

TABLE NO . 52 : Comparisonof cardiovascular parameters (SBP, DBP, MAP & HR ) among group - 1 and group - 2.

 

GROUP

N

MEDIAN

IQR ( 75 th – 25 th

 

percentile )

STD

P- VALUE

HR

 

( Bpm )

GROUP  1

GROUP 2

50

 

50

76

 

78.5

9.5 (81.75-72.25)

11.75 (82 –70.25)

7.437

7.951

 

 

0.689

SBP

 

( mmHg )

GROUP  1

GROUP 2

50

 

50

110

100

20 ( 120– 100 )

20 ( 110– 90 )

10.498

13.702

 

 

0.003 **

DBP

 

( mmHg )

GROUP 1

 

GROUP 2

50

 

50

70

 

70

10 ( 80 – 70 )

10 ( 70 – 60 )

8.819

 

7.475

 

 

0.010 *

MAP

 

( mmHg )

GROUP  1

GROUP 2

50

 

50

86.667

80

13.33 ( 93.33– 80 )

10( 83.33-73.33)

8.841

8.583

 

 

0.002**

 

( ** highly significant )

 

OBSERVATION : Systolic blood pressure , Diastolic blood pressure and Mean arterial pressure was significantly higher in Group 1 subjects compared to Group 2 subjects .

 

FIGURE NO . 7: Box and whisker              plot showing comparison of          HR between               group 1 and group 2 individuals.

 

FIGURE NO . 8 : Box and whisker plot showing comparison of SBP between group -1 and group -2 individuals .

 

FIGURE NO . 9 : Box and             whisker plot showing comparison of DBP between group 1 and group 2 individuals.

 

FIGURE NO .10 : Box and            whisker plot showing comparison of          MAP between group 1 and group 2 individuals.

 

OBSERVATION : There is significant difference of cardio vascular parameters   among group 1    and group 2. Box and whisker plot showing significantly higher SBP, DBP and MAP in group 1 individuals .

 

TABLE NO . 6 : Comparison of time domain parameters between group 1 and group 2.

 

 

 

 

 

PARA-METER

 

 

GROUP - 1

 

 

GROUP - 2

 

MEDIAN

IQR ( 75 – 25 th

Percentile )

MEDIAN

IQR ( 75 – 25 th

Percentile )

P - VALUE

MEAN HR

 

(Bpm)

80.5

12 (86 -74 )

83.5

13.5 (88 -74.5)

0.1

SDNN

49.85

22.6       (59.725              -

42.2

12.85 (48.8 - 35.97)

0.018 *

(ms)

 

37.125 )

 

 

 

RMSSD

51.7

29.825 (65.475 -

41.8

15.35 (51.87-36.55)

0.046 *

(ms)

 

35.65)

 

 

 

PNN50

19.91

33.585(42.512-

18.78

18.95 (27.96-8.785)

0.156

(%)

 

8.927)

 

 

 

 

(* significant)

 

OBSERVATION : Time     domain parameters like SDNN , RMSSD were            significantly lower in Group 2 subjects . 42

 

FIGURE NO . 11 : Box and whisker plot showing comparison of Mean HR between group 1 and group 2 individuals.

 

FIGURE NO . 12 : Box and whisker plot showing comparison of     SDNN between group 1 and group 2 individuals .

 

FIGURE NO .13:              Box        and whisker plot showing comparison of   RMSSD between group 1 and group 2 individuals .

 

FIGURE NO . 14 : Box and whisker plot showing comparison of     PNN50 between group 1 and group 2 individuals.

 

OBSERVATION : There is significant difference of Time    Domain Paramerters between group 1 and group 2. Box and whisker plot showing significantly lower SDNN and RMSSD in group 2 individuals.

 

TABLE NO . 7 : Comparison of Frequency Domain Parameters between group 1 and group 2 .

 

 

 

 

Parameter

 

 

GROUP - 1

 

 

GROUP - 2

 

MEDIAN

IQR ( 75 – 25

 

th Percentile )

MEDIAN

IQR ( 75 – 25 th

Percentile )

P-VALUE

LF nu

45.74

21.61 (57.26 -

35.65)

47.215

22.035(61.67 -39.63)

0.269

HF nu

54.2

22.063(64.76 -

51.61

23.665          (60.24                      –

0.143

 

 

42.70)

 

36.58)

 

LF / HF ratio

0.85

0.751(1.337                             -

 

0.586)

0.937

1.047 (1.705– 0.658)

0.29

 

OBSERVATION : Frequency          domain parameters like LF nu, HF nu , LF / HF ratio were not showing significant differences .

 

FIGURE NO . 15: Box and whisker plot showing comparison of lf nu between group 1 and group 2 individuals.

 

FIGURE NO 16: Box       and whisker plot showing comparison of HF nu between group 1 and group 2 individuals.

 

FIGURE NO . 17 : Box and whisker plot showing comparison of LF /HF ratio between group 1 and group 2 individuals.

 

OBSERVATION : Box       and         whisker plot        showing no significant difference    of frequency domain parameters between group 1 and group 2 individuals.

Risk of developing low HRV in Group 2 compared to Group 1:

 

The        75 th      quartile of            SDNN is 52.6 and the 75 th quartile of RMSS is 56.05 Number of people with SDNN lower than         52.6 in Group-1 is 32 and Group-2 is 43.

Number of people with RMSSD lower than 56.05 in Group-1  is 34 and Group-2 is 41.

 

The assumption is that SDNN and RMSSD values higher than 75 th quartile is having good autonomic reactivity.

Anything lower than 75 th quartile of SDNN Value 52. 6 is considered as low SDNN and higher than 52.6 is considered as high SDNN.

 

Anything lower than          75 th quartile of RMSSD   Value 56.05         is considered as low RMSSD               and higher than 56.05        is considered as high RMSSD .

 

TABLE NO. 8: Frequency distribution of high SDNN and RMSSD between Group 1 and Group 2 individuals.

 

SDNN HIGH

SDNN LOW

RMSSD HIGH

RMSSD LOW

GROUP -1

18

32

16

34

GROUP-2

7

43

9

41

 

The        risk of low HRV paramerters in Group 2 as defined by risk ratio is calculated and found to be :

The Risk ratio calculated  for  low  SDNN  will be 43/32  = 1.34.

 

The Risk ratio calculated  for  low  RMSSD will be 41/34 = 1.20

 

The odds of having  low SDNN in group - 2 can be calculated from the same table no: 23.

ODDS RATIO for low SDNN  = Odds in group - 2 / Odds in group – 1=  0.289

 

The odds of having  low RMSSD in group - 2 can be calculated  from  the same table no : 23.

 

ODDS RATIO for low RMSSD       = Odds in group - 2 / Odds in group – 1 =  0.466

 

TABLE NO . 9 : Odds ratio analysis of  low SDNN and Low RMSSD.

 

ODDS RATIO (ln)

CI ( LOWER , UPPER )

P-VALUE

SDNN

0.964

( - 0.068 , - 0.006 )

0.021 *

RMSSD

0.976

(- 0.049, 0 )

0.046 *

 

OBSERVATION : Odds of having low SDNN              and low RMSSD is higher in Group 2 than Group 1 indicating poor HRV in Group 2 individuals.

 

DISCUSSION

EXPLANATION OF THE RESULTS :

The resting short term analysis of HRV shows the following results .

The SBP was significantly increased in the Group-1 ( control ) than Group-2 (study ) which is unusual with respect to the patho physiology of Covid-19. Hence, it could be an incidental finding.

 

COVID - 19 is found to increase sympathetic stimulation. Sympathetic stimulation increases BP by; 1) Vasoconstriction of resistance vessels 2) Venoconstriction (Increases venous return) 3) Cardiac stimulation (Increases heart rate and myocardial contractility) 4) Increased secretion of catecholamine from adrenal medulla 6.

 

The DBP was significantly  increased  in the Group-1 than Group - 2.

The MAP was significantly increased in the Group-1 than Group - 2.MAP is a average pressure recorded during the cardiac cycle. It is influenced by the cardiac output and systemic vascular resistance .

 

Autonomic nervous system plays an important role in regulating MAP .When MAP is increased , there is increased baroreceptor stimulation, the Nucleus tractus sollitarius decreases the sympathetic output and ultimately the result is a subsequent decrease in MAP.

 

Another study aimed to assess Ambulatory BP and BP variability in young population of 2 groups . Group 1  has 28 participants who had covid -19 before 11 weeks and Group 2 has 10 controls , ambulatory daytime , night time and 24 hour SBP,DBP and MAP were measured     and         found     out         that               there is no significant difference between control and study group. This study also suggest that Covid -19 only exerts only shorter effects on BP         in young adults 7 One more study did a cross sectional study comprising of two groups . Group 1 ( participants who had SARS - COV infection before 6 months and non hospitalized ) and Group 2 ( Age and gender matched healthy controls ).Cardiovascular risk factors , physical functioning and arterial stiffness were assessed for two groups. Cardiovascu lar risk factor was estimated by BP, Cardiac troponin I and CRP , Cardio femoral pulse wave velocity  was   used  to  measure  arterial stiffness. Hand  grip  strength , gait speed ,accelerometry and questionnaire on fatigue was evaluated for assessing physical functioning .Study finding concluded that there is no significant difference in CV risk factors, CV biomarkers and arterial stiffness between two groups 9.

 

A cohort study, with two group - Group 1 had no history of COVID - 19 infection and posted for painless gastrointestinal endoscopy . Group 2 had history of COVID - 19 infection and posted for same procedure .SBP , DBP ,MAP were recorded before and after induction and observed that there is blood pressure variability in DBP and MAP in the Group -2 . This clearly indicates the impact of COVID 19 on cardiovascular changes . These findings were contradicted to our study 11.

 

In our study , we have not measured BP prior to the Covid infection 12 .

Regular cardio vascular parameters may not be able to pick up initial variations in the sympathovagal balance like HRV which has higher sensitivity.13

 

Time domain parameters like SDNN, RMSSD were lower in study group than control group               which    means    a withdrawal        of           parasympathetic system . There is a significant change in             Time domain parameters like RMSSD and   SDNN in long C O V I D clinical group. 1 3

 

Ertugrul kurtoglu et al .,2021 ,conducted a study in a COVID -19 recovered individuals and evaluates cardiac autonomic function using HRV and found out that Time domain parameters like SDNN , RMSSD were all decreased in the study group than control group 14-15

 

Another study conducted by Hani Taman et al ,2023,did HRV analysis in myocardial injured covid 19 patients and Non myocardial injured covid 19 patients and found that Time domain parameters like SDNN and RMSSD were significantly reduced in myocardial injured covid 19 patients . This study also proves that HRV as a prognostic tool for diagnosing covid -19 induced cardiac dysautonomia. Our study shows similar finding but the study participants does not have any history of any myocardial injury16 .

 

Indian study conducted by Bhushan Shah et al. , 2022, to determine the prevalence of cardiac dysautonomia using AI model of  HRV in 92 Covid -19 recovered individuals and 120 healthy volunteers and witnessed that one of the Time Domain Parameter (RMSSD) was significantly lower in the post covid -19 patients than healthy controls. This study is showing similar findings as that of our study 17 .

 

Another Indian study conducted by Senthamizhsevan et al ., in 2024. It was an analytical and observational study in male population of age range ( 30 to 70 years ) and compared the autonomic reactivity using 5 minute lead - II HRV in study group who were in the period of 3 - 6 months following recovery from covid -19( n= 21 )    with age matched healthy control group( n= 21). Results estimated showing Frequency domain HRV Indices of LF Power , HF Power and Total Power were significantly reduced in the Covid -19 recovery group than control group which proves that there is depressed cardiac autonomic modulation in the study group. In our study , none of the frequency                   domain measures were found to be statistically significant 1 8 .

 

Adang et al , 2023 did a retrospective cohort study in the hospital of Netherland. This study was conducted in a 171 patients who got admitted in hospital for Covid - 19 infection between February and December 2020 .The aim of their study was to look for association between HRV recorded during admission and Pulmonary Function Test ( PFT ) recorded beyond 3 months after covid– 19 infection.Multinomial logistic regression model was performed for analysis. Their sample size was not sufficient to show Odds ratio closer to 1.00 than 0.63. Their result showed that there is no association between HRV and impaired pulmonary function after 3 months of Covid -19 infection . In our study , Odds ratio calculated for lower SDNN is 0.289 and for low RMSSD is 0.466. Odds of having low SDNN and RMSSD is higher in group - 2 than group -1 individuals 19.

 

STRENGTH OF THE STUDY :

GROUP 2 ( N= 50 ) who were RT PCR positive for Covid -19. RT-PCR is a validated tool approved by ICMR [53].The study population comprising of  young adults (18 - 30 years) which is a unidentified population and they are gender matched. The early detection of cardiac dysautonomia can help the young individuals to modify their life style and seek advise from Health care Experts 2 0 .

 

LIMITATIONS : Covid Negative state was not tested in Group - 1.Some study participants may be infected with Covid - 19 virus and remain asymptomatic and untested. This may lead to grouping error. Multiple new strains of  Covid - 19 have emerged during Covid pandemic. For e.x) Alpha ( B.1.1.7 ) ,( B.1.351),Gamma ( P.1 ) , Delta ( B.1.617.2 ) and Omicron ( B.1.1.529 ). Each Covid strain has different virulence and transmissibility rate [55]. But , this was not compared in the present study. Most of the participants got Covid -19 infection after getting vaccinated against COVID -19. Since COVID -19 vaccine has cardioprotective role, severity of Long Covid on cardiac autonomic function might be different from unvaccinated population .This was not compared in the present study. Follow up was not done for study participants with reduced HRV, in order to determine the persistence of altered autonomic function in these population .

 

FUTURE IMPLICATIONS :

This study can be further elaborated as a Basic Science Research ( ex , Cell culture and Animal models ) . Animal model can be done by inducing Covid -19 virus in them and the pathophysiology of Long COVID 19 can be studied.. In Cell Culture, the levels of cytokines and neurotransmitters modifications due to COVID - 19 can be studied. This study can be expanded in clinical set up and laboratories.(ex, Screening the Out patient department with H/O COVID - 19 infection in the past and testing them with biochemical and pathological tests). Clinicians can watch out for Long covid symptoms like fatigue, anxiety, insomnia and rule out other causes in young population and advice them for Life style modification.

 

REFERENCES:

  1. Marques KC , Silva CC , Silva Trindade S et al.Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID.Frontiers in Cardiovascular Medicine, 2022 ; 9:8620.DOI: 10.3389/fcvm.2022.862001.
  2. Zygmunt A, Stanczyk J. Methods of evaluation of autonomic nervous system function. Arch Med Sci. 2010;6(1):11-18. DOI :10.5114/aoms.2010.13500.
  3. Dani M, Dirksen AA, Taraborrelli BP et al.Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clinical Medicine 2021;21(1):e63-7.
  4. Marques KC , Silva CC , Silva Trindade S et al.Reduction of Cardiac Autonomic Modulation and Increased
  5. Sympathetic Activity by Heart Rate Variability in Patients With Long COVID.Frontiers in Cardiovascular Medicine, 2022 ; 9:8620.DOI: 10.3389/fcvm.2022.862001.
  6. Ahmad MS, Shaik RA, Ahmad RK et al.“LONG COVID”: an insight. European Review for Medical and Pharmacological Sciences .2021; 25: 5561-5577. doi: 10.26355/eurrev_202109_26669
  7. K.Pal, Textbook of Practical Physiology, Fifth edition, Universities press,Hyderabad, ,2020
  8. Nandadeva D, Skow R.J, Grotle AK et al.Impact of COVID-19 on ambulatory blood pressure in young adults: a cross-sectional analysis investigating time since diagnosis.Journal of Applied Physiology. 2022;133(1): 183–190,. DOI:10.1152/japplphysiol.00216.2022.
  9. Van der Sluijs K M , Bakker E A ,Schuijt TJ et al.Long-term cardiovascular health status and physical functioning of nonhospitalized patients with COVID-19 compared with non-COVID-19 controls. American Journal of Physiology .2023;324: H47–H56.DOI:10.1152/ajpheart.00335.2022
  10. Lian Z, Qin F, Huang Y et al.The impact of novel coronavirus infection on blood pressure variability in patients undergoing painless gastrointestinal endoscopy. Journal of Anesthesia and Translational Medicine 3.2024;17–20.DOI: https://doi.org/10.1016/j.jatmed.2024.02.005.
  11. Petrosillo N, Viceconte G, Ergonul O et al.COVID-19, SARS and MERS: are they closely related? Clinical Microbiology and Infection.2020;20: 729-734.DOI:https://doi.org/10.1016/j.cmi.2020.03.026.
  12. Lian Z, Qin F, Huang Y et al.The impact of novel coronavirus infection on blood pressure variability in patients undergoing painless gastrointestinal endoscopy. Journal of Anesthesia and Translational Medicine 3.2024;17–20.DOI: https://doi.org/10.1016/j.jatmed.2024.02.005.
  13. Azami P, Vafa RG , Heydarzadeh R et al. Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study. BMC Cardiovascular Disorders .2024 ;24(1):240.DOI: https://doi.org/10.1186/s12872-024-03916-w.
  14. Peabody JE , Ryznar R, Ziesmann M et al . A Systematic Review of Heart Rate Variability as a Measure of Stress in Medical Professionals.Cureus.2023;15(1): e34345. DOI: 10.7759/cureus.34345.
  15. Kurtoğlu E, Afsin A, Aktaş I et al.Altered cardiac autonomic function after recovery from COVID - 19, Ann Noninvasive Electrocardiol. 2022;27(1):e12916.DOI: 10.1111/anec.12916.
  16. Taman H, Mageed N, Elmorsy M et al.Heart rate variability as an indicator of COVID-19 induced myocardial injury: a retrospective cohort study. BMC Anesthesiology .2023; 23:17.DOI:
  17. 16 Shah B , Kunal S, Bansal A et al. Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence. Indian Pacing and Electrophysiology.
  18. 2022 ;22 (2)70-76. DOI:https://doi.org/10.1016/j.ipej.2022.01.004.
  19. Senthamizselvan R, Tharion E, George K et al.Cardiac Autonomic Dysfunction Measured as Reduced Heart Rate Variability, in the Intermediate Post-Covid State in Men. Current Medical Issues , 2024 ;22( 1) :14-20.DOI: 10.4103/cmi.cmi_71_23.
  20. Adang E , Strous M , van den Bergh JP et al. Association of Heart Rate Variability with Pulmonary Function Impairment and Symptomatology Post-COVID-19 Hospitalization .Sensors. 2023;23(5):
  21. Saha S and Sharma K.Modification of Lifestyle to Recover from Post-COVID Symptoms: A Short Review, Journal of Lifestyle Medicine.2022;12 (3). DOI:https://doi.org/10.15280/jlm.2022.12.3.113
  22. Mercadé-Besora N, Li X, Kolde R et al.The role of COVID-19 vaccines in preventing post COVID-19 thromboembolicand cardiovascular complications.Heart .2024;0:1–9
Recommended Articles
Research Article Open Access
Symptom Dimensions and Insight in Obsessive Compulsive Disorder: A Cross-Sectional Study in A Tertiary Care Hospital at Kolkata
2026, Volume-7, Issue 4 : 3100-3107
Research Article Open Access
Diagnostic Accuracy of Ultrasonography in Acute Pancreatitis: A Prospective Validation Using Contrast-Enhanced Computed Tomography as the Reference Standard
2026, Volume-7, Issue 4 : 3076-3082
Research Article Open Access
A Comprehensive Study of Distribution and Relation of ABO and RH Blood Group Antigens with Body Mass Index Among Medical Students
2026, Volume-7, Issue 4 : 3071-3075
Research Article Open Access
Intraocular Pressure Changes in the Affected and Fellow Eyes of Patients with Unilateral Retinal Vein Occlusion: A Prospective Observational Study
2025, Volume-6, Issue-3 : 278-281
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
4 Views
8 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved